Purpose: Neutrophil gelatinase-associated lipocalin (NGAL) is a protein belonging to the lipocalin superfamily and plays a role in atherosclerosis, renal injury and inflammation. The present study aimed to investigate serum NGAL concentrations in groups of patients with dipper and non-dipper hypertension (HT) and to characterize the relationship between NGAL concentration and circadian blood pressure in hypertensive patients.
Hypertension (HT) is a disease that may lead to multiple target organ injury, and eventually to death due to related vascular system injury [1] . In addition to the presence of well recognized cardiovascular risk factors, alterations in circadian (nighttime-daytime) blood pressure level are also associated with disease prognosis. Blood pressure has been reported to decrease by 10-20% at night in a majority of HT patients (dipper) and by <10% at night in the remaining HT patients (nondipper) [2] [3] [4] . Studies have demonstrated that non-dipper HT patients are at a higher risk for atherosclerotic events (myocardial and cerebral infarction), progressive nephropathy and cardiovascular mortality than dipper HT patients [5] [6] [7] [8] .
Neutrophil gelatinase-associated lipocalin (NGAL) is a protein that belongs to the lipocalin superfamily and is released primarily from neutrophils, as well as from renal tubular cells and the endothelium, in response to inflammation and vascular injury [9, 10) ] Studies have demonstrated that NGAL is a good predictor of renal injury and prognosis [11, 12] . Moreover, NGAL has been shown to play a role in atherosclerotic inflammation [13, 14] and NGAL concentrations are significantly increased in coronary artery disease (CAD) and are closely associated with severity of CAD [15, 16] .
These results suggest that NGAL, which is both a renal and a cardiovascular predictor, might also play a role in altered nighttime blood pressure. In the present study, we investigate serum NGAL concentrations in dipper and non-dipper HT patient groups and determine the relationship of NGAL concentration with circadian blood pressure in hypertensive patients.
Materials and Methods

Study population
Our patient population consisted of dipper and non-dipper HT patients who were diagnosed via ambulatory blood pressure monitoring (ABPM). The patient population included 41 non-dipper HT patients (22 male, 19 female, mean age: 56.1 ±8.9 years) and 40 age-and gender-matched dipper HT patients (19 male, 21 female, mean age: 54.0 ±10.0 years). In addition, the study population included 42 age-and gendermatched healthy volunteers (20 male, 22 female, mean age: 54.4 ±8.5 years).
Patients with secondary hypertension, coronary artery disease, renal insufficiency (creatinine-based estimated glomerular filtration rate (GFR) <90 ml/min/1.73 m 2 calculated by the Cockcroft-Gault formula), acute and chronic inflammatory disease, significant valvular disease, hematological disease, systolic heart failure (ejection fraction <45%), diabetes mellitus, atrial fibrillation and/or cerebrovascular disease were excluded. The local ethics committee approved the study protocol and informed consent was taken from all the patients.
Clinical BP measurements
BP measurements were taken for all patients after a 5 minute resting period and while the patients were sitting with their arm at heart level. The cuff of the blood pressure measuring device surrounded 80% of the upper arm and the distal end was 2.5-3 cm above the antecubital fossa [17] . Hypertension was defined by a systolic blood pressure (SBP) ≥ 140 mmHg and/ or diastolic blood pressure (DBP) ≥90 mmHg during clinical BP measurements, or a history of taking antihypertensive medication [18] .
Ambulatory blood pressure monitoring and dipping status
Twenty-four hour ABPM was performed using a portable digital recorder (Custo Med, Custo Screen 100, Germany). The device was set to take measurements at 15 minute intervals between 07:00 and 23:00 for daytime BP values and at 30 minute intervals between 23:00 and 07:00 for nighttime BP values. The recordings were analyzed by interactive software. Daytime, nighttime and 24 hour average SBP and DBP values and mean BP values were calculated for each patient using hourly averages of ambulatory BP recordings. Those with a 24 hour mean SBP >130 mmHg and/or DBP >80 mmHg were considered hypertensive [18] . Percentage decrease in nighttime blood pressure was calculated using the formula "Nighttime BP decrease (%) = (Daytime BP − Nighttime BP) × 100/Daytime BP'' . Hypertensive patients were dichotomized as dipper (≥10%) or non-dipper (<10%) according to the nighttime decrease in systolic and diastolic blood pressures [2] [3] [4] .
Biochemical Measurements
Blood samples of selected individuals were collected between 8:00 and 10:00 am in the morning after 8-12 hours of fasting in order to avoid influences of diurnal rhythm. The samples were centrifuged and sera were separated. Routine biochemical and hematological parameters were analyzed on the same day. The sera were stored at -80 o C until lipocalin-2/NGAL levels were analyzed using ELISA. Biochemical parameters were measured using commercial kits and a Abbott ARCHITECT c8000 (Abbott Laboratories, USA) auto-analyzer. Hematological parameters were analyzed by laser and impedance methods using the Abbott CellDyn 3700 (Abbott Laboratories, USA) device. High sensitive C-reactive protein (hs-CRP) (CardioPhase, hs-CRP) was measured quantitatively in a BN II 
Results
Baseline clinical characteristics
Baseline clinical characteristics of the patients are shown in 
Serum NGAL levels
Serum NGAL concentrations were significantly higher in the non-dipper and dipper HT patient groups than in the control group (84.9 ±23.0 ng/ml and 62.1 ±17.8 vs. 46.6 ±13.7 ng/ml, p<0.017, respectively) ( Table 1) . Moreover, serum NGAL concentrations of the non-dipper HT group were significantly higher than those of the dipper HT group (p < 0.017) ( Figure  1 ).
Ambulatory blood pressure values
Although no significant differences were determined between non-dipper and dipper HT patient groups in terms of daytime 
Association of serum NGAL levels with ambulatory blood pressure levels and laboratory findings
Serum NGAL concentration showed significant correlation with overall ambulatory BP levels in both non-dipper and dipper groups (Table 3) . Although NGAL concentrations were strongly correlated with nighttime SBP, DBP and mean BP values, they were only moderately correlated with daytime SBP, DBP and mean BP values (Figure 2 ). There was a significant positive correlation between serum NGAL levels and hs-CRP levels (r =0.602, p<0.001, Figure 3 ) and a significant negative correlation between serum NGAL levels and GFR values in the non-dipper HT and dipper HT patient groups ( r = -0.489, p<0.001 and r = -0.389, p<0.001, respectively). Multivariate analysis demonstrated that the non-dipper BP pattern was associated with serum NGAL levels (standardized ß coefficient = 0.054, p<0.001), serum hs-CRP levels (standardized ß coefficient = 0.042, p=0.005) and LDL cholesterol levels (standardized ß coefficient = 0.032, p=0.033) in the multivariate stepwise logistic regression model (Table 4) . Standardized ß coefficients and P values were 0.706 and 0.369 for age, 0.048 and 0.743 for BMI, 0.569 and 0.356 for smoking, 0.031 and 0.501 for fasting glucose, respectively.
Discussion
In the present study, higher NGAL concentrations were identified in non-dipper HT patients in comparison with those in dipper HT and normotensive patients. Moreover, serum NGAL concentrations showed significant correlation with daytime, nighttime and 24 hour BP values.
HT is a well-known risk factor for cardiovascular diseases, renal insufficiency and stroke [1] . Clinical studies have demonstrated that the incidence of end-organ injury is higher in nondipper HT patients, who are diagnosed based on a 24 hour ABPM that shows a nocturnal BP decrease <10% [19, 20] . Even though the mechanism of non-dipper HT has not yet been determined, studies have demonstrated that autonomic dysfunction, increased sympathetic activity, a sedentary life style and volume-related factors play a role in the pathogenesis [21, 22] .
NGAL is a 25 kDa glycoprotein that was first isolated from neutrophils and has been found to be covalently bonded to the matrix metalloproteinase-9 (MMP-9) [9] . Studies have shown that serum and urinary NGAL concentrations are increased in the early phase of acute renal injury [23] . Moreover, it is thought that NGAL secreted from endothelial cells might play a role in inflammation that is associated with endothelial dysfunction and atherosclerosis [13, 24] . Recent studies have demonstrated that serum NGAL concentrations are increased in CAD and might contribute to the atherosclerotic process [16, 25] .
HT is not only an increase in blood pressure, but is also a complex cardiovascular disease, where inflammation, endothelial dysfunction and platelet activation also play a role in pa- [26] . Increased inflammatory activity has been demonstrated in HT patients [27] and higher inflammatory activity in non-dipper than in dipper HT patients has been shown in studies investigating the relationship between circadian blood pressure and inflammatory markers such as Creactive protein (CRP), gamma-glutamyltranspeptidase (GGT) and uric acid [2, 28] . Clinical studies investigating the relationship between serum NGAL concentrations and inflammation demonstrated that levels of serum NGAL reflect the systemic inflammatory response in stroke, renal insufficiency and infection settings [29] [30] [31] . Kafkas et al. [32] determined that NGAL concentrations were higher in acute coronary syndrome (ACS) patients in comparison with stable angina patients. Moreover, serum NGAL concentrations were found to be correlated with neutrophil count and CRP concentrations. Linberg et al. [33] found that increased NGAL concentrations are associated with all-cause mortality and inflammation. Similarly, in our study serum hs-CRP levels were significantly higher in non-dipper HT patient group in comparison with dipper HT and control groups and there was a significant positive correlation between hs-CRP levels and serum NGAL suggesting that higher serum NGAL concentrations in the non-dipper HT group might be related to higher inflammatory activity in this group. High blood pressure is known to lead to endothelial dysfunction [34] . A previous study detected impaired endothelium-dependent vasodilation through a decrease in levels of acetylcholine (Ach) and nitric oxide (NO), which arose from endothelial dysfunction in non-dipper HT patients compared with dipper HT patients [35] . Impaired endothelial function is associated with cardiovascular and cerebrovascular diseases, both of which are more prevalent in non-dipper HT patients [35] . Kim et al. [36] reported that endothelial progenitor cells, which play a key role in endothelial homeostasis and vascular repair, are less prevalent in the circulation of nondipper than dipper HT patients. In addition, aortic stiffness, which increases with atherosclerosis and endothelial dysfunction [37] , has been shown to be increased in non-dipper HT patients compared with dipper HT patients [38, 39] . Considering that NGAL, which is regarded as a plasma marker of neutrophil activation, increases in endothelial dysfunction and contributes to the development of atherosclerosis [13, 40] , the high serum NGAL concentrations found in non-dipper HT patients might be due to endothelial dysfunction, which is more prevalent in non-dipper HT patients.
A reduced nocturnal decrease in blood pressure has been associated with a higher incidence of end-organ injury and an unfavorable clinical outcome [41] and Ortiz et al. (LOD-RISK study) showed a higher incidence of renal injury among nondipper HT patients than dipper HT patients [42] . Likewise, Timio et al. [5] conducted a long-term follow-up study of 48 HT patients with renal insufficiency and reported that renal insufficiency showed faster progression in the non-dipper than the dipper HT group. Previous studies have documented the relationship between serum NGAL concentrations and renal dysfunction [23] . Although patients with renal dysfunction were excluded from the present study, a significant negative correlation was observed between serum NGAL levels and GFR values. A subclinical renal damage due to decreased GFR levels may be contributing to the increased serum NGAL levels of non-dipper and dipper HT patient groups; therefore, higher serum NGAL concentrations detected in non-dipper HT patients in the present study may be an early sign of renal dysfunction. Elneihoum et al. [29] investigated the relationship between plasma leukocyte activation markers and risk factors of atherosclerotic vascular disease. The researchers determined that plasma NGAL concentration shows positive correlation with blood pressure. Park et al. [43] found that serum NGAL levels were 85.0±37.6 ng/ml in patients with essential HT and 43.8±13.1 ng/ml in the normotensive control group; a statistically significant difference. Additionally, a significant correlation was found between serum NGAL levels and all blood pressure values (SBP, DBP and mean BP). These results are similar to those obtained in the present study. In their study on patients with advanced carotid artery stenosis, Giaginis et al. [44] demonstrated that serum NGAL levels were 64.21-118.29 (median: 81.71 ng/ml) in hypertensive patients, and 56.01-94.55 ng/ml (median: 75.41 ng/ml) in normotensive patients. The serum NGAL levels of patients were higher than those of our study; carotid atherosclerosis may contribute higher serum NGAL levels in these patients. Additionally, in our study, serum NGAL level was found by multivariate analysis to be an independent determinant factor of non-dipper blood pressure. Thus, serum NGAL levels may have promising predictive value in determining non-dipper blood pressure, which carries a high risk of cardiovascular mortality. In our study, serum NGAL concentrations showed the highest correlation with nighttime blood pressure values; in particular, a significant positive correlation between serum NGAL concentrations and nighttime blood pressure values suggests that there might be a relationship between the cardiovascular events caused by nighttime high blood pressure values and serum NGAL concentrations.
Study Limitations
A major limitation of our study was the small sample size of the study population, and as such we were not able to fully evaluate the prognostic value of serum NGAL levels in patients with HT; future studies could include using a larger patient cohort. Urinary NGAL levels were not determined, although measurement of urinary NGAL levels and comparison of urinary and serum NGAL levels may prove to play a complementary role in determining cardiovascular and renal damage in the hypertensive patient group. Although additional inflammatory and vascular markers, which could be indicators of endothelial dysfunction, were not measured in our study, their investigation would be a worthwhile area of research.
Conclusion
The present study is the first to demonstrate that serum NGAL concentrations increased significantly in non-dipper HT patients compared with both dipper HT patients and normotensive patients, and showed significant correlation with ambulatory blood pressure values. Increases in serum NGAL concentrations could be interpreted as a combined outcome of endothelial dysfunction, inflammation and renal injury in nondipper HT patients. Moreover, serum NGAL concentrations might be a useful marker for determining HT patients with higher risk for cardiovascular mortality. Larger-scale prospective studies would help to validate our findings.
